The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Open Access
- 1 July 2002
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 110 (1) , 3-8
- https://doi.org/10.1172/jci16127
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of ras (KSR)Journal of Molecular Biology, 2002
- Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in MiceScience, 2001
- Molecular Mechanisms of Ceramide-Mediated CD95 ClusteringBiochemical and Biophysical Research Communications, 2001
- Enzymes of Sphingolipid Metabolism: From Modular to Integrative SignalingBiochemistry, 2001
- Inhibition of PKB/Akt1 by C2-Ceramide Involves Activation of Ceramide-Activated Protein Phosphatase in PC12 CellsMolecular and Cellular Neuroscience, 2000
- Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pHJournal of Biological Chemistry, 1998
- Association of p75 with Caveolin and Localization of Neurotrophin-induced Sphingomyelin Hydrolysis to CaveolaeJournal of Biological Chemistry, 1997
- Compartmentalized Production of Ceramide at the Cell SurfacePublished by Elsevier ,1995
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- Sphingomyelin and derivatives as cellular signalsProgress in Lipid Research, 1991